Ballentine Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,957
| Closed | -$393K | – | 424 |
|
|
2019
Q3 | $393K | Buy |
3,957
+194
| +5% | +$19.3K | 0.02% | 242 |
|
|
2019
Q2 | $348K | Buy |
3,763
+533
| +17% | +$49.3K | 0.02% | 266 |
|
|
2019
Q1 | $305K | Buy |
+3,230
| New | +$305K | 0.02% | 242 |
|
|
2018
Q4 | – | Sell |
-3,148
| Closed | -$281K | – | 390 |
|
|
2018
Q3 | $281K | Buy |
3,148
+456
| +17% | +$40.7K | 0.01% | 269 |
|
|
2018
Q2 | $214K | Sell |
2,692
-1,574
| -37% | -$125K | 0.01% | 308 |
|
|
2018
Q1 | $380K | Sell |
4,266
-689
| -14% | -$61.4K | 0.02% | 224 |
|
|
2017
Q4 | $518K | Sell |
4,955
-1,924
| -28% | -$201K | 0.03% | 184 |
|
|
2017
Q3 | $1M | Sell |
6,879
-234
| -3% | -$34.1K | 0.06% | 119 |
|
|
2017
Q2 | $967K | Buy |
7,113
+2,245
| +46% | +$305K | 0.07% | 130 |
|
|
2017
Q1 | $606K | Sell |
4,868
-258
| -5% | -$32.1K | 0.04% | 107 |
|
|
2016
Q4 | $564K | Buy |
5,126
+343
| +7% | +$37.7K | 0.04% | 97 |
|
|
2016
Q3 | $500K | Sell |
4,783
-109
| -2% | -$11.4K | 0.04% | 98 |
|
|
2016
Q2 | $483K | Sell |
4,892
-135
| -3% | -$13.3K | 0.04% | 113 |
|
|
2016
Q1 | $504K | Buy |
5,027
+2,318
| +86% | +$232K | 0.04% | 106 |
|
|
2015
Q4 | $324K | Buy |
2,709
+15
| +0.6% | +$1.79K | 0.03% | 133 |
|
|
2015
Q3 | $292K | Buy |
2,694
+522
| +24% | +$56.6K | 0.03% | 134 |
|
|
2015
Q2 | $251K | Buy |
2,172
+27
| +1% | +$3.12K | 0.02% | 137 |
|
|
2015
Q1 | $247K | Sell |
2,145
-2
| -0.1% | -$230 | 0.02% | 137 |
|
|
2014
Q4 | $240K | Buy |
+2,147
| New | +$240K | 0.03% | 140 |
|